We are live on ! Find out more
MMRF

Michelson Medical Research Foundation Portfolio holdings

AUM $108M
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$3.53M
Cap. Flow
+$1.17M
Cap. Flow %
0.77%
Top 10 Hldgs %
67.01%
Holding
28
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GXC icon
State Street SPDR S&P China ETF
GXC
+$1.17M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Real Estate 13.34%
2 Energy 4.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HYG icon
1
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
$19.7M 13.02%
255,130
– –
BKLN icon
2
Invesco Senior Loan ETF
BKLN
$6.78B
$12.7M 8.39%
600,610
– –
BSV icon
3
Vanguard Short-Term Bond ETF
BSV
$45.7B
$12.7M 8.37%
164,845
– –
VWO icon
4
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$9.73M 6.41%
236,630
– –
IVE icon
5
iShares S&P 500 Value ETF
IVE
$50.3B
$9.03M 5.95%
51,905
– –
IVV icon
6
iShares Core S&P 500 ETF
IVV
$894B
$8.59M 5.67%
17,989
– –
AVB
7
DELISTED
AvalonBay Communities
AVB
$8.33M 5.49%
44,485
– –
HDV
8
iShares Core High Dividend ETF
HDV
$15.3B
$7.47M 4.93%
366,200
– –
VEA icon
9
Vanguard FTSE Developed Markets ETF
VEA
$239B
$7.3M 4.81%
361,160
– –
KRE icon
10
State Street SPDR S&P Regional Banking ETF
KRE
$4.05B
$6.01M 3.97%
114,700
– –
IBB icon
11
iShares Biotechnology ETF
IBB
$10.8B
$5.9M 3.89%
43,395
– –
PLD icon
12
Prologis
PLD
$136B
$5.65M 3.73%
42,405
– –
ARE icon
13
Alexandria Real Estate Equities
ARE
$9.12B
$4.72M 3.11%
37,230
– –
IWC icon
14
iShares Micro-Cap ETF
IWC
$1.52B
$4.11M 2.71%
35,385
– –
VB icon
15
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
$4.03M 2.66%
18,910
– –
CRC icon
16
California Resources
CRC
$4.67B
$3.2M 2.11%
58,450
– –
EWZ icon
17
iShares MSCI Brazil ETF
EWZ
$8.19B
$2.84M 1.87%
81,300
– –
EWW icon
18
iShares MSCI Mexico ETF
EWW
$1.8B
$2.84M 1.87%
41,850
– –
XBI icon
19
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$2.79M 1.84%
31,300
– –
PFF icon
20
iShares Preferred and Income Securities ETF
PFF
$13.1B
$2.56M 1.69%
81,970
– –
CRGY icon
21
Crescent Energy
CRGY
$4.42B
$2.06M 1.36%
156,166
– –
TALO icon
22
Talos Energy
TALO
$2.79B
$1.99M 1.31%
139,780
– –
BXP icon
23
Boston Properties
BXP
$11.2B
$1.53M 1.01%
21,735
– –
EWY icon
24
iShares MSCI South Korea ETF
EWY
$27.9B
$1.32M 0.87%
20,155
– –
EWJ icon
25
iShares MSCI Japan ETF
EWJ
$22.6B
$1.29M 0.85%
20,100
– –
1
2

Similar funds

SA
SPWM Advisors Traverse City, Michigan $108M AUM
BC
Bayforest Capital London, United Kingdom $108M AUM 45.71% 1-Year Est. Return
SF
Schuylkill Financial Wyomissing, Pennsylvania $108M AUM
UFA
Unify Financial Advisors Clearwater, Florida $108M AUM
YEPX
Yorktown Energy Partners XI New York $108M AUM 57.73% 1-Year Est. Return
YAIA
Yanni & Associates Investment Advisors Wexford, Pennsylvania $108M AUM
BCM
Barden Capital Management Austin, Texas $108M AUM 19.73% 1-Year Est. Return
RRA
Red Reef Advisors Boca Raton, Florida $108M AUM

Michelson Medical Research Foundation's Q4 2023 Portfolio in Review

As of Q4 2023, Michelson Medical Research Foundation held 28 positions worth $152M, up 2.4% from $148M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.6%. Michelson Medical Research Foundation opened 1 new position and made no exits, leaving the 28-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 13% of assets, up from 12% a quarter earlier, followed by Energy.

  • Michelson Medical Research Foundation's largest Q4 2023 buy was State Street SPDR S&P China ETF: 16,750 shares worth $1.14M.
  • Michelson Medical Research Foundation's ten largest holdings make up 67% of its $152M portfolio in Q4 2023.
  • Michelson Medical Research Foundation opened 1 new position and closed 0 in Q4 2023.
  • Michelson Medical Research Foundation's portfolio value rose 2.4% quarter-over-quarter to $152M.

Based on Michelson Medical Research Foundation's 13F filing for Q4 2023, filed 14 Feb 2024.